Just published on @ESMO_Open our latest Open Access review on HER3, a promising yet elusive drug target, that we’re finally understanding how to exploit for cancer treatment. Led by Drs Uliano (@jacopo14473142) & Corvaja (@carlacorvaja_) from @curijoey Lab
https://t.co/BiRSHobSAn
Comprehensive yet concise overview on anti #HER3 strategies, now on @ESMO_Open. Check it out! Targeting HER3 for cancer treatment: a new horizon for an old target https://t.co/lO26r2Dq4O w/ the precious help of @carlacorvaja_@curijoey and @PTarantinoMD
This is us!! An international team of researchers, scientists, doctors & administrators. Our mission is to bring the #benchtothebedside & treat each patient with personalized #precisionmedicine! We know that #liquidbiopsy is the new era in cancer treatment! @MCristofanill